Palvella Therapeutics, Inc. (PVLA)
PVLA price $126.33 +2.41 +1.94%
- Ticker
- PVLA
- Price
- $126.33
- Change
- +2.41 +1.94%
- Market cap
- $1.82B
- P/E
- -25.66
- Forward P/E
- 133.49
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic…